Ove Bruland Selected Research

Ove Bruland Research Topics

Disease

12	Neoplasms (Cancer) 01/2022 - 08/2002
3	Fatigue 12/2016 - 01/2011
3	Papillary Thyroid Cancer 12/2009 - 08/2002
2	Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) 01/2022 - 01/2011
2	Acoustic Neuroma (Acoustic Neurinoma) 01/2022 - 12/2018
2	Chronic Brain Damage 12/2016 - 01/2016
2	Congenital Stromal Corneal Dystrophy 05/2015 - 11/2010
2	Carcinoma (Carcinomatosis) 03/2012 - 02/2006
2	Squamous Cell Carcinoma of Head and Neck 03/2011 - 11/2008
2	Hyperthermia 02/2009 - 03/2008
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2024
1	Hypercholesterolemia 01/2024
1	Keloid 01/2023
1	Pterygium 01/2023
1	Neurofibrosarcoma (MPNST) 01/2022
1	Premature Aging 01/2021
1	Acro-Osteolysis (Acroosteolysis) 01/2019
1	Myofibromatosis 01/2019
1	Progeria (Hutchinson Gilford Syndrome) 01/2019
1	Low Vision (Subnormal Vision) 01/2019
1	Lipodystrophy 01/2019
1	Microsatellite Instability 01/2018
1	Gaucher Disease (Gaucher's Disease) 01/2017
1	Necrosis 01/2016
1	Neutropenia 01/2015
1	Hypersensitivity (Allergy) 01/2015
1	Cognitive Dysfunction 09/2014
1	Sjogren's Syndrome (Sjogren Syndrome) 07/2011
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2011
1	Autoimmune Diseases (Autoimmune Disease) 01/2011
1	Lymphoma (Lymphomas) 01/2011
1	Corneal Opacity 11/2010
1	Neurofibromatosis 2 (Neurofibromatosis Type II) 10/2010
1	Thyroiditis 12/2009
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2009
1	Glioma (Gliomas) 02/2009
1	Meningioma (Meningiomas) 07/2008
1	Arachnoid Cysts (Intracranial Arachnoid Cysts) 07/2008
1	Mouth Neoplasms (Oral Cancer) 11/2007
1	Acute Intermittent Porphyria (Porphyria, Acute) 01/2004

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 09/2015 - 02/2006
4	Messenger RNA (mRNA)IBA 10/2010 - 08/2002
4	Complementary DNA (cDNA)IBA 10/2010 - 08/2002
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2007
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 07/2008
3	Rituximab (Mabthera)FDA Link 01/2016 - 01/2011
3	RNA (Ribonucleic Acid)IBA 12/2009 - 07/2008
2	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 01/2022 - 01/2019
2	Oxidoreductases (Dehydrogenase)IBA 12/2016 - 07/2008
2	DecorinIBA 05/2015 - 11/2010
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2009 - 03/2008
1	CholesterolIBA 01/2024
1	InflammasomesIBA 01/2023
1	Codon (Codons)IBA 01/2021
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2019
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2019
1	Nucleic AcidsIBA 12/2018
1	Glucosylceramides (Glucocerebrosides)IBA 01/2017
1	Pyruvic Acid (Pyruvate)IBA 12/2016
1	B-Cell Activating FactorIBA 01/2016
1	Immunoglobulins (Immunoglobulin)IBA 01/2016
1	Nonsense Codon (Nonsense Mutation)IBA 09/2014
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 07/2011
1	Matrix Metalloproteinases (MMPs)IBA 03/2011
1	AutoantibodiesIBA 01/2011
1	Transforming Growth Factor beta3 (TGF beta 3)IBA 10/2010
1	Thymidylate SynthaseIBA 07/2008
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 02/2006
1	NucleotidesIBA 02/2006
1	LigandsIBA 02/2006
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2006
1	Kallikreins (Kallikrein)IBA 02/2006
1	OsteopontinIBA 02/2006
1	Fibronectins (Fibronectin)IBA 02/2006
1	Dual-Specificity PhosphatasesIBA 02/2006
1	Growth Differentiation Factor 15IBA 02/2006
1	Serine Proteases (Serine Protease)IBA 02/2006
1	Claudin-1IBA 02/2006
1	IntegrinsIBA 02/2006
1	Cadherins (E-Cadherin)IBA 02/2006
1	Trans-Activators (Trans-Acting Factor)IBA 02/2006
1	glutaminyl-peptide cyclotransferaseIBA 02/2006
1	PotassiumIBA 02/2006
1	PeriostinIBA 02/2006
1	claudin 16IBA 02/2006
1	Hydroxymethylbilane Synthase (Porphobilinogen Deaminase)IBA 01/2004

Therapy/Procedure

3	Aftercare (After-Treatment) 12/2009 - 08/2008
2	Therapeutics 12/2009 - 11/2008
1	Ligation 01/2018
1	Drug Therapy (Chemotherapy) 01/2011